Idarucizumab for Reversing Dabigatran-Induced Anticoagulation: A Systematic Review
Conclusions:
Given the increased use of direct oral anticoagulants, such as dabigatran, a need for specific reversal agents exists. Idarucizumab has been shown to be safe and effective in the reversal of dabigatran-induced anticoagulation in patients requiring emergent or urgent surgery or in patients with severe bleeding.
Source: American Journal of Therapeutics - Category: Drugs & Pharmacology Tags: Systematic Review and Clinical Guidelines Source Type: research
More News: Back Pain | Bleeding | Clinical Trials | Common Cold | Constipation | Coumadin | Drugs & Pharmacology | Emergency Medicine | Headache | Migraine | Pain | Pneumonia | Pradaxa | Skin | Study | Warfarin